These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19070809)

  • 41. Pancreatic metastases of renal cell carcinoma--case report.
    Shukla RC; Pathak R; Senthil S
    Nepal Med Coll J; 2008 Dec; 10(4):275-7. PubMed ID: 19558071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.
    Oudard S; Medioni J; Aylllon J; Barrascourt E; Elaidi RT; Balcaceres J; Scotte F
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):705-17. PubMed ID: 19496707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?
    Bamias A; Lainakis G; Manios E; Koroboki E; Karadimou A; Zakopoulos N; Dimopoulos MA
    J Clin Oncol; 2009 May; 27(15):2567-9; author reply 2569-70. PubMed ID: 19332708
    [No Abstract]   [Full Text] [Related]  

  • 44. Metastatic renal cell carcinoma to the pancreas with splenic portal vein tumor thrombus.
    Pestana IA; David-West G; Livingstone A
    Am Surg; 2008 Apr; 74(4):359-60. PubMed ID: 18453307
    [No Abstract]   [Full Text] [Related]  

  • 45. [Radiotherapy in treatment of relapsing renal cell cancer].
    Metelev VV; Zharinov GM
    Vopr Onkol; 2008; 54(6):775-7. PubMed ID: 19241859
    [No Abstract]   [Full Text] [Related]  

  • 46. Metastatic thyroid carcinoma: a case from Australia.
    Anderson S; O'Connor C
    N Z Med J; 2006 Jun; 119(1235):U2013. PubMed ID: 16751831
    [No Abstract]   [Full Text] [Related]  

  • 47. Re: Capitanio et al.: Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (Urology 2008;72:1090-1095).
    Chung SD; Chu SH; Tsai CC
    Urology; 2009 Mar; 73(3):682-3; author reply 683-4. PubMed ID: 19248907
    [No Abstract]   [Full Text] [Related]  

  • 48. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.
    Machado NO; Chopra P
    JOP; 2009 Jul; 10(4):413-8. PubMed ID: 19581746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concurrent application of bisphosphonates and external beam radiotherapy in patients with metastatic bone disease from renal cancer.
    Vassiliou V; Leotsinides M; Kalogeropoulou C; Kardamakis D
    BJU Int; 2009 Aug; 104(3):417-8; author reply 418. PubMed ID: 19614659
    [No Abstract]   [Full Text] [Related]  

  • 51. Update on the use of mTOR inhibitors in renal cell carcinoma.
    Rini BI
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):722-4. PubMed ID: 18997660
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquired perforating dermatosis heralding metastatic renal cell carcinoma to the liver.
    Kurban M; Uthman I; Kibbi AG; Ghosn S
    Int J Dermatol; 2008 Oct; 47(10):1038-40. PubMed ID: 18986351
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anti-angiogenic therapies and hemorrhagic risk].
    Ayllon J; Pignot G
    Prog Urol; 2010 Mar; 20 Suppl 1():S20-2. PubMed ID: 20493438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Healing and targeted therapies: Management in perioperative period?].
    Pignot G; Lebret T; Chekulaev D; Peyromaure M; Saighi D; Flam T; Amsellem-Ouazana D; Debre B; Zerbib M
    Prog Urol; 2011 Mar; 21(3):166-72. PubMed ID: 21354033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of renal cell carcinoma with intracardiac extension.
    Posacioglu H; Ayik MF; Zeytunlu M; Amanvermez D; Engin C; Apaydin AZ
    J Card Surg; 2008; 23(6):754-8. PubMed ID: 19017006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A gingival swelling].
    Hammami S; Krichen Makni S; Ellouze S; Mnif H; Fakhfakh I; Gouiaa N; Dhouib M; Sellami-Boudawara T
    Rev Stomatol Chir Maxillofac; 2007 Nov; 108(5):471-2. PubMed ID: 17640693
    [No Abstract]   [Full Text] [Related]  

  • 57. Metastasis to the oral cavity.
    Lewis DM
    J Okla Dent Assoc; 2008 Oct; 99(11):28-9. PubMed ID: 19058730
    [No Abstract]   [Full Text] [Related]  

  • 58. Angiogenesis inhibitors and hypertension: an emerging issue.
    Sica DA
    J Clin Oncol; 2006 Mar; 24(9):1329-31. PubMed ID: 16446321
    [No Abstract]   [Full Text] [Related]  

  • 59. From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential future directions of the field.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):286-7. PubMed ID: 18836332
    [No Abstract]   [Full Text] [Related]  

  • 60. Diuretics and renal cell carcinoma--what the practicing physician needs to know.
    Messerli FH
    Schweiz Med Wochenschr; 1999 Apr; 129(15):577-8. PubMed ID: 10355017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.